Authors:
CENTORRINO F
BALDESSARINI RJ
FRANKENBURG FR
KANDO J
VOLPICELLI SA
FLOOD JG
Citation: F. Centorrino et al., SERUM LEVELS OF CLOZAPINE AND NORCLOZAPINE IN PATIENTS TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS, The American journal of psychiatry, 153(6), 1996, pp. 820-822
Citation: Rj. Baldessarini et al., EFFECTS OF FLUOXETINE ON SERUM CLOZAPINE LEVELS - REPLY, The American journal of psychiatry, 152(3), 1995, pp. 473-474
Authors:
CENTORRINO F
BALDESSARINI RJ
KANDO J
FRANKENBURG FR
VOLPICELLI SA
PUOPOLO PR
FLOOD JG
Citation: F. Centorrino et al., SERUM CONCENTRATIONS OF CLOZAPINE AND ITS MAJOR METABOLITES - EFFECTSOF COTREATMENT WITH FLUOXETINE OR VALPROATE, The American journal of psychiatry, 151(1), 1994, pp. 123-125
Authors:
VOLPICELLI SA
CENTORRINO F
PUOPOLO PR
KANDO J
FRANKENBURG FR
BALDESSARINI RJ
FLOOD JG
Citation: Sa. Volpicelli et al., DETERMINATION OF CLOZAPINE, NORCLOZAPINE, AND CLOZAPINE-N-OXIDE IN SERUM BY LIQUID-CHROMATOGRAPHY, Clinical chemistry, 39(8), 1993, pp. 1656-1659
Authors:
WHITE K
KANDO J
PARK T
WATERNAUX C
BROWN WA
Citation: K. White et al., THE ISSUE OF SIDE-EFFECTS AND THE BLINDABILITY OF CLINICAL DRUG TRIALS - REPLY, The American journal of psychiatry, 150(11), 1993, pp. 1760-1761